1-{[(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidinium chloride hydrochloride hydrate (1: 1:1:1)(CAS: 123171-59-5)

This compound has a crystalline form and a molecular weight of approximately 614.3 g/mol. It exhibits good solubility in water and organic solvents. The compound is reactive towards nucleophiles and bases. It can form hydrogen bonds, which contribute to its crystalline structure and solubility properties.

This compound is typically synthesized through a multi-step process involving the condensation of a thiazole derivative with an amino acid derivative. The reaction involves the use of a catalytic amount of a suitable acid or base as a catalyst. The yield and selectivity of the reaction are influenced by the reaction conditions, including temperature and solvent choice.

This compound is used in the pharmaceutical industry for its potential as a drug candidate. It may also find applications in the polymer industry for its reactivity and functional groups, and in the sensor industry due to its ability to interact with specific analytes.

Proper personal protective equipment (PPE) should be worn, including gloves, goggles, and a lab coat. Handling should be done in a fume hood to minimize exposure. Spills should be cleaned up carefully using appropriate solvents and waste should be disposed of according to local regulations. Always refer to the safety data sheet (SDS) for detailed information on handling and storage.